Device Trial Radar · NCT07827287
Utility of the Perclose ProGlide™ Suture-Mediated Closure Device After Cardiologic Procedures Via the Femoral Vein Approach (Eight-Clover)
Last checked: Nov 20, 2026Latest source record: Sep 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Enrolling by invitation
Enrollment
200
Planned (sponsor's estimate)
Start
Feb 2, 2026
Primary completion
May 31, 2028
Study completion Dec 31, 2028
Sponsor
- Lead sponsor
- Ewha Womans University Mokdong HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Ewha Womans University Seoul Hospital
- First posted
- Sep 18, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 19 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the clinical efficacy and safety of the Perclose ProStyle™ Suture-Mediated Closure Device in patients undergoing cardiologic procedures via a femoral vein approach using a sheath size of 8 French or larger.Patients receiving cardiac interventions-such as atrial fibrillation catheter ablation, leadless pacemaker insertion, atrial septal defect (ASD) patch closure, or left atrial appendage occlusion (LAAO)-will be randomly assigned in a 1:1 ratio to either the intervention group (using the Perclose ProStyle™ device for vascular closure) or the control group (using conventional manual compression or figure-of-eight suture).The primary outcome of the study is the time to ambulation after the procedure. Secondary outcomes include time to hemostasis, time to discharge eligibility, patient satisfaction scores, and the incidence of vascular complications within 30 days post-procedure.
Conditions
- Atrial Fibrillation
- Atrial Septal Defect
- Vascular Closure Device
Interventions
Perclose ProStyle™ Suture-Mediated Closure SystemDevice
Vascular closure device applied to the femoral vein access site immediately following sheath removal.
Conventional Hemostasis (Manual Compression or Figure-of-Eight Suture)Other
Hemostasis achieved using standard manual compression or figure-of-eight suture technique at the femoral vein access site.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to AmbulationTime frame: Up to 24 hours post-procedure
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Ewha Womans University Mokdong Hospital
Seoul, South Korea
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.